This letter is aimed at health professionals who are responsible for commissioning and operationally delivering the national NHS shingles vaccination programme. It is important to ensure that those at greatest risk are vaccinated at an earlier age and this forms the basis of the JCVI recommendations. ![]() This is based on recommendations from the Joint Committee on Vaccination and Immunisation ( JCVI).Īlthough shingles can occur at any age, the risk and severity of shingles and its complications increases with age and is high in individuals who are immunosuppressed. In addition to this, the eligibility for the immunocompromised and immunocompetent cohorts will change to allow individuals to be protected at an earlier age. ![]() This letter provides information about forthcoming changes to the NHS shingles vaccination programme.įrom 1 September 2023, all newly eligible individuals will be offered 2 doses of the non-live shingles vaccine Shingrix® instead of Zostavax®.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |